Advertisement
Research Article

PPARα siRNA–Treated Expression Profiles Uncover the Causal Sufficiency Network for Compound-Induced Liver Hypertrophy

  • Xudong Dai mail,

    To whom correspondence should be addressed. E-mail: xudong_dai@merck.com (XD); yudong_he@merck.com (YDH)

    Affiliation: Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Angus T. De Souza,

    Affiliation: Preclinical Molecular Profiling, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Hongyue Dai,

    Affiliation: Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • David L Lewis,

    Affiliation: Mirus Bio Corporation, Madison, Wisconsin, United States of America

    X
  • Chang-kyu Lee,

    Affiliation: Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Andy G Spencer,

    Affiliation: Mirus Bio Corporation, Madison, Wisconsin, United States of America

    X
  • Hans Herweijer,

    Affiliation: Mirus Bio Corporation, Madison, Wisconsin, United States of America

    X
  • Jim E Hagstrom,

    Affiliation: Mirus Bio Corporation, Madison, Wisconsin, United States of America

    X
  • Peter S Linsley,

    Affiliation: Cancer Biology, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Douglas E Bassett,

    Affiliation: Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Roger G Ulrich,

    Affiliation: Preclinical Molecular Profiling, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Yudong D He mail

    To whom correspondence should be addressed. E-mail: xudong_dai@merck.com (XD); yudong_he@merck.com (YDH)

    Affiliation: Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

    X
  • Published: March 02, 2007
  • DOI: 10.1371/journal.pcbi.0030030

Reader Comments (0)

Post a new comment on this article